Nippon Chemiphar Co Ltd has managed to “nearly level year-on-year sales” as the company reported that it had managed to limit the decline in its pharmaceuticals sales to just 0.7% for the financial year ending 31 March 2021.
The full-year stable sales figure comes after the Japanese company reported a 7.5% rate of year-on-year decline in its pharmaceuticals...







